Literature DB >> 1958526

Hormonal regulation of cathepsin D following transfection of the estrogen or progesterone receptor into three sex steroid hormone resistant cancer cell lines.

I Touitou1, F Vignon, V Cavailles, H Rochefort.   

Abstract

The cathepsin D gene is differentially regulated by estrogens in hormone responsive breast cancer cells, by progestins in normal human endometrium and is highly expressed but not regulated by these steroids in estrogen (RE)- and progesterone receptor (RP)-negative breast cancer cells. We have stably transfected the RE-negative breast cancer cell line MDA-MB 231 and the Hela cell line with an expression vector for the human RE. The endogenous cathepsin D which is constitutively expressed was further stimulated by estradiol. However, the growth of both cell lines was not stimulated by estradiol and could not be inhibited by the antiestrogen ICI 164,384. By contrast, the cathepsin D gene in the estrogen responsive Ishikawa endometrial cancer cell line was unresponsive to estrogen or to progesterone even following stable transfection of expression vectors for the RP (both A and B isoforms). We conclude that the cathepsin D gene is potentially responsive to estrogens in MDA-MB 231 and Hela cells, which therefore express all of the transcriptional machinery (except the RE) necessary for this regulation. By contrast, cathepsin D remains unresponsive to estrogen and progesterone in Ishikawa cells. The cathepsin D gene is one of the first examples of an endogenous steroid responsive gene which can be controlled by steroids following stable transfection of a steroid receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958526     DOI: 10.1016/0960-0760(91)90187-a

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  10 in total

1.  ER beta inhibits proliferation and invasion of breast cancer cells.

Authors:  G Lazennec; D Bresson; A Lucas; C Chauveau; F Vignon
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

2.  CORRELATIONSHIP OF CATHEPSIN D AND TOPOISOMERASE II ALPHA WITH NUCLEAR GRADING IN BREAST CANCERS.

Authors:  Prabal Deb; G U Deshpande
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  The role of histone modifications and variants in regulating gene expression in breast cancer.

Authors:  Mathieu Dalvai; Kerstin Bystricky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-02-04       Impact factor: 2.673

4.  Western blotting and isoform analysis of cathepsin D from normal and malignant human breast cell lines.

Authors:  L D Laury-Kleintop; E C Coronel; M K Lange; T Tachovsky; S Longo; S Tucker; J A Alhadeff
Journal:  Breast Cancer Res Treat       Date:  1995-08       Impact factor: 4.872

5.  Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions.

Authors:  Mickey V Patel; Mimi Ghosh; John V Fahey; Christina Ochsenbauer; Richard M Rossoll; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2014-05-08       Impact factor: 3.886

6.  Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer.

Authors:  W Remmele; J Sauer-Manthey
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells.

Authors:  M Garcia; D Derocq; G Freiss; H Rochefort
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells.

Authors:  V Cavaillès; P Augereau; H Rochefort
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

9.  Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z.

Authors:  Luca Bellucci; Mathieu Dalvai; Silvia Kocanova; Fatima Moutahir; Kerstin Bystricky
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

10.  Effects of adiponectin on breast cancer cell growth and signaling.

Authors:  M E Grossmann; K J Nkhata; N K Mizuno; A Ray; M P Cleary
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.